विधियों की तुलना करें

	डीवीटी के लिए वेल्स स्कोर	CURB-65 निमोनिया गंभीरता स्कोर	qSOFA Score
क्षेत्र	नैदानिक मूल्यांकन	नैदानिक मूल्यांकन	नैदानिक मूल्यांकन
परिवार	Process / pipeline	Process / pipeline	Process / pipeline
उद्भव वर्ष	1994	2003	2016
प्रवर्तक	Philip S. Wells	W. Staniford Lim, et al.	Sepsis-3 Taskforce
प्रकार	Venous thromboembolism risk stratification	Community-acquired pneumonia severity assessment	Rapid sepsis screening
मौलिक स्रोत	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.	Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
उपनाम	Wells DVT Score, DVT Wells	CURB-65, Pneumonia severity	Quick SOFA, qSOFA
संबंधित	3	3	3
सारांश	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.	CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.